We all have our own healthcare story - whether managing a chronic condition or helping a loved one navigate an illness. It’s often during this journey that you experience firsthand how difficult it is to gain access to the health data and information that give patients and caregivers a full picture of one's health.
Welcome to our blog
Today, I’m excited to share that doc.ai has entered into a definitive agreement to be acquired by Sharecare, the digital health company that helps people manage all their health in one place.
doc.ai was founded with the bold mission of unlocking the value of real world data from research to care. We’ve worked on breaking down data silos in healthcare ultimately increasing the pace of innovation and creating pathways to better health outcomes.
The COVID-19 pandemic has led to a dramatic increase in the use of virtual and digital mental health services. Since the pandemic and associated lockdowns has left more people in need with less ability to access in-person care, virtual care and other digital tools are more important than ever in supporting existing care, providing scale and increasing capacity.
Passport by doc.ai is a private, customizable solution to help company leaders and teams get back to business safely. Today, Passport is used in 800+ locations around the US by more than 100 employers including financial institutions, hotels and hospitality, entertainment, schools and construction companies.
Students, parents and university administrators are learning that the pandemic poses unique challenges for college campuses, ranging from speed testing, to self-attestation and access points, to students struggling with social isolation.
Mid-November, some of the best minds transforming the healthcare experience in real life and real-time met at the 7th Annual emids Healthcare Summit. This year, the summit focused on making digital health doable at an unprecedented pace and scale.
It’s time to become an expert for the survival of your business.
Since I co-founded doc.ai, I have spent a lot of time talking with business leaders from the healthcare industry, but with the arrival of the pandemic my conversations have expanded to leaders and CEOs outside of healthcare, from all industries.
Today we’re excited to announce a new collaboration with UCB, a multinational biopharma company headquartered in Brussels, Belgium, with the launch of a digital health trial for myasthenia gravis, a neuromuscular disease that can lead to impaired speech, blurred vision, difficulty swallowing, and other symptoms.
Recent advancements for COVID-19 vaccines are promising, at the same time, COVID-19 hospitalization rates are spiking across the country. In today’s environment, health and safety guidelines will continue to evolve and employers need support to quickly adapt their return to work programs by location and industry.